Author: Nadia Hindi, MD, MSc – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology
### @@@ Javier Martinez-Trufero, MD – HU Miguel Servet ### 2102401###Co-Author###Medical Oncologist###HU Miguel Servet###Co-Author: Javier Martinez-Trufero, MD – HU Miguel Servet
### @@@ Giovanni Grignani, MD – Candiolo Cancer Institute, FPO – IRCCS ### 2101864###Co-Author######Candiolo Cancer Institute, FPO – IRCCS###Co-Author: Giovanni Grignani, MD – Candiolo Cancer Institute, FPO – IRCCS
### @@@ Ana Sebio, MD, PhD (she/her/hers) – Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. ### 2101849###Co-Author###Consultant###Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.###Co-Author: Ana Sebio, MD, PhD (she/her/hers) – Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
### she/her/hers @@@ Sandra Strauss, MD, PhD – University Collegue of London (UCL) ### 2102402###Co-Author######University Collegue of London (UCL)###Co-Author: Sandra Strauss, MD, PhD – University Collegue of London (UCL)
### @@@ Silvia Stacchiotti, MD (she/her/hers) – Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2102240###Co-Author###Consultant###Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Silvia Stacchiotti, MD (she/her/hers) – Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### she/her/hers @@@ Enrique Gonzalez-Billalabeitia, MD – HU Doce de Octubre ### 2102403###Co-Author###Medical Oncologist###HU Doce de Octubre###Co-Author: Enrique Gonzalez-Billalabeitia, MD – HU Doce de Octubre
### @@@ Irene Carrasco Garcia, MD – Virgen del Rocio University Hospital ### 2102229###Co-Author###Medical Oncologist###Virgen del Rocio University Hospital###Co-Author: Irene Carrasco Garcia, MD – Virgen del Rocio University Hospital
### @@@ Rafael Ramos, MD, PhD – HU Son Espases ### 2102404###Co-Author######HU Son Espases###Co-Author: Rafael Ramos, MD, PhD – HU Son Espases
### @@@ Antonio Gutierrez, MD, PhD – HU Son Espases ### 2102405###Co-Author######HU Son Espases###Co-Author: Antonio Gutierrez, MD, PhD – HU Son Espases
### @@@ David S. Moura, PhD (he/him/his) – Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), ### 2102206###Co-Author###Molecular biologist###Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM),###Co-Author: David S. Moura, PhD (he/him/his) – Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM),
### he/him/his @@@ Patricio Ledesma, . – Sofpromed ### 2102406###Co-Author######Sofpromed###Co-Author: Patricio Ledesma, . – Sofpromed
### @@@ Javier Martin-Broto, MD, PhD (he/him/his) – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology ### 2101868###Co-Author###Medical oncology###Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology###Co-Author: Javier Martin-Broto, MD, PhD (he/him/his) – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology
### he/him/his Paper 32Author: Dario Callegaro, MD – Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### @@@ Francesco Barretta, PhD – Fondazione IRCCS IStituto Nazionale dei Tumori, Milan, Italy ### 2101964###Co-Author###Health Researcher###Fondazione IRCCS IStituto Nazionale dei Tumori, Milan, Italy###Co-Author: Francesco Barretta, PhD – Fondazione IRCCS IStituto Nazionale dei Tumori, Milan, Italy
### @@@ Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School ### 1137185###Co-Author###Surgical Oncologist###Brigham and Women’s Hospital/Harvard Medical School###Co-Author: Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School
### he/him/his @@@ Wendy Johnston, PhD (she/her/hers) – Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada ### 2101966###Co-Author###Sarcoma Clinical Research Manager###Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada###Co-Author: Wendy Johnston, PhD (she/her/hers) – Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada
### she/her/hers @@@ Dirk Strauss, MD – Royal Marsden NHS Foundation Trust ### 2101967###Co-Author###Surgical Oncologist###Royal Marsden NHS Foundation Trust###Co-Author: Dirk Strauss, MD – Royal Marsden NHS Foundation Trust
### @@@ Charles Honorè, MD, PhD – Institut Gustave Roussy, Villejuif, France ### 2101968###Co-Author######Institut Gustave Roussy, Villejuif, France###Co-Author: Charles Honorè, MD, PhD – Institut Gustave Roussy, Villejuif, France
### @@@ Sylvie Bonvalot, MD, PhD – Institut Curie ### 2101969###Co-Author###Head, Sarcoma surgery###Institut Curie###Co-Author: Sylvie Bonvalot, MD, PhD – Institut Curie
### @@@ Mark Fairweather, MD – Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston ### 2101970###Co-Author###Surgical Oncologist###Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston###Co-Author: Mark Fairweather, MD – Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston
### @@@ Piotr L. Rutkowski, MD, PhD – Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw Poland ### 2101971###Co-Author###Head of Department of Soft Tissue/Bone Sarcoma and Melanoma###Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw Poland###Co-Author: Piotr L. Rutkowski, MD, PhD – Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw Poland
### @@@ Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute/ Antoni van Leeuwenhoek ### 2101972###Co-Author###Surgical Oncology###Netherlands Cancer Institute/ Antoni van Leeuwenhoek###Co-Author: Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute/ Antoni van Leeuwenhoek
### @@@ Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON ### 2101973###Co-Author###Surgical Oncologist Clinician-Scientist Associate Professor of Surgery###Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON###Co-Author: Rebecca Gladdy, MD, PhD (she/her/hers) – Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON
### she/her/hers @@@ Fabio Tirotta, MD – Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust ### 2101974###Co-Author###Sarcoma Surgical Oncologist ###Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust###Co-Author: Fabio Tirotta, MD – Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust
### @@@ Dimitri Tzanis, MD, PhD (he/him/his) – Institut Curie ### 2101975###Co-Author###Consultant Surgical Oncologist###Institut Curie###Co-Author: Dimitri Tzanis, MD, PhD (he/him/his) – Institut Curie
### he/him/his @@@ Jacek Skoczylas, MD – Maria Sklodowska-Curie National Research Institute of Oncology ### 2101976###Co-Author######Maria Sklodowska-Curie National Research Institute of Oncology###Co-Author: Jacek Skoczylas, MD – Maria Sklodowska-Curie National Research Institute of Oncology
### @@@ Rick Haas, MD, PhD (he/him/his) – The Netherlands Cancer Institute ### 2101977###Co-Author###Senior staff member###The Netherlands Cancer Institute###Co-Author: Rick Haas, MD, PhD (he/him/his) – The Netherlands Cancer Institute
### he/him/his @@@ Rosalba Miceli, MD, PhD (she/her/hers) – Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2101978###Co-Author###Director of Unit of Biostatistics for Clinical Research###Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Rosalba Miceli, MD, PhD (she/her/hers) – Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### she/her/hers @@@ Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada ### 2101979###Co-Author######Mount Sinai Hospital, Toronto, ON, Canada###Co-Author: Carol Swallow, MD, PhD – Mount Sinai Hospital, Toronto, ON, Canada
### @@@ Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2101980###Co-Author###Chief Sarcoma Service and Chair of the Department of Surgery###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### he/him/his Paper 79Author: Reuben Hastings, MSc – NHS England, UCL Cancer Institute
### @@@ Andrew Bacon, MSc – NHS England ### 2102178###Co-Author###Senior Genomic Analyst###NHS England###Co-Author: Andrew Bacon, MSc – NHS England
### @@@ Victoria Vinader, PhD – Bone Cancer Research Trust ### 2102179###Co-Author###Research Manager###Bone Cancer Research Trust###Co-Author: Victoria Vinader, PhD – Bone Cancer Research Trust
### @@@ Sean McPhail, PhD – National Disease Registration Service, NHS England ### 2102180###Co-Author######National Disease Registration Service, NHS England###Co-Author: Sean McPhail, PhD – National Disease Registration Service, NHS England
### @@@ Lizz Paley, MSc (she/her/hers) – NHS England ### 2102181###Co-Author###Partnerships Analytical Lead###NHS England###Co-Author: Lizz Paley, MSc (she/her/hers) – NHS England
### she/her/hers @@@ Martin G. McCabe, PhD – University of Manchester ### 2102182###Co-Author###Clinical senior lecturer###University of Manchester###Co-Author: Martin G. McCabe, PhD – University of Manchester
### @@@ Craig Gerrand, MD, FRCS Ed (Tr and Orth) – Royal National Orthopaedic Hospital ### 2102183###Co-Author###Consultant Orthopaedic Surgeon###Royal National Orthopaedic Hospital###Co-Author: Craig Gerrand, MD, FRCS Ed (Tr and Orth) – Royal National Orthopaedic Hospital
### @@@ Sandra J. Strauss, MD PhD FRCP (she/her/hers) – UCL Cancer Institute ### 2102184###Co-Author###Professor of Medical and TYA Oncology###UCL Cancer Institute###Co-Author: Sandra J. Strauss, MD PhD FRCP (she/her/hers) – UCL Cancer Institute
### she/her/hers Paper 68Author: Sebastian Bauer, MD (he/him/his) – Department of Medical Oncology, West German Cancer Center, University Hospital Essen
### he/him/his @@@ Jean-Yves Blay, MD, PhD – Centre Léon-Bérard ### 2101899###Co-Author###PUPH###Centre Léon-Bérard###Co-Author: Jean-Yves Blay, MD, PhD – Centre Léon-Bérard
### @@@ Ping Chi, MD, PhD (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2101910###Co-Author###Member/Professor and Attending Physician###Memorial Sloan Kettering Cancer Center###Co-Author: Ping Chi, MD, PhD (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Robin L. Jones, BSc, MB BS, MRCP, MD – Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research ### 2101847###Co-Author###Consultant Medical Oncologist###Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research###Co-Author: Robin L. Jones, BSc, MB BS, MRCP, MD – Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
### @@@ César Serrano, MD, PhD – Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain ### 2101911###Co-Author######Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain###Co-Author: César Serrano, MD, PhD – Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain
### @@@ Neeta Somaiah, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2101912###Co-Author###Associate Professor and Deputy Chair###The University of Texas MD Anderson Cancer Center###Co-Author: Neeta Somaiah, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ William Reichmann, PhD – Deciphera Pharmaceuticals, LLC ### 2101913###Co-Author###Senior Director, Head of Clinical Biostatistics###Deciphera Pharmaceuticals, LLC###Co-Author: William Reichmann, PhD – Deciphera Pharmaceuticals, LLC
### @@@ Kam Sprott, PhD (she/her/hers) – Deciphera Pharmaceuticals, LLC ### 2101914###Co-Author###Executive Director of Translational Medicine###Deciphera Pharmaceuticals, LLC###Co-Author: Kam Sprott, PhD (she/her/hers) – Deciphera Pharmaceuticals, LLC
### she/her/hers @@@ Haroun Achour, MD – Deciphera Pharmaceuticals, LLC ### 2101915###Co-Author######Deciphera Pharmaceuticals, LLC###Co-Author: Haroun Achour, MD – Deciphera Pharmaceuticals, LLC
### @@@ Matthew L. Sherman, MD – Deciphera Pharmaceuticals, LLC ### 2101891###Co-Author######Deciphera Pharmaceuticals, LLC###Co-Author: Matthew L. Sherman, MD – Deciphera Pharmaceuticals, LLC
### @@@ Rodrigo Ruiz-Soto, MD/MSc (he/him/his) – Deciphera Pharmaceuticals, LLC ### 2101890###Co-Author###Sr. Vice President Clinical Development###Deciphera Pharmaceuticals, LLC###Co-Author: Rodrigo Ruiz-Soto, MD/MSc (he/him/his) – Deciphera Pharmaceuticals, LLC
### he/him/his @@@ Michael C. Heinrich, MD – Portland VA Health Care System and Oregon Health & Science University Knight Cancer Institute ### 2101916###Co-Author###Professor of Medicine###Portland VA Health Care System and Oregon Health & Science University Knight Cancer Institute###Co-Author: Michael C. Heinrich, MD – Portland VA Health Care System and Oregon Health & Science University Knight Cancer Institute
### @@@ Suzanne George, MD – Dana-Farber Cancer Institute ### 2101917### Co-Author######Dana-Farber Cancer Institute###Co-Author: Suzanne George, MD – Dana-Farber Cancer Institute
### Paper 61Author: Erik Blomain, MD PhD – Thomas Jefferson University
### @@@ Shaghayegh Soudi, PhD – Stanford University ### 2102683###Co-Author######Stanford University###Co-Author: Shaghayegh Soudi, PhD – Stanford University
### @@@ Anish Somani, Undergraduate Student – Stanford University ### 2102684###Co-Author###Researcher###Stanford University###Co-Author: Anish Somani, Undergraduate Student – Stanford University
### @@@ Ajay Subramanian, BS – Stanford University ### 2102685###Co-Author###Bioinformatician###Stanford University###Co-Author: Ajay Subramanian, BS – Stanford University
### @@@ Neda Nemat-Gorgani, MS – Stanford University ### 2102686###Co-Author######Stanford University###Co-Author: Neda Nemat-Gorgani, MS – Stanford University
### @@@ Everett J. Moding, MD, PhD (he/him/his) – Stanford University ### 2102687###Co-Author###Assistant Professor###Stanford University###Co-Author: Everett J. Moding, MD, PhD (he/him/his) – Stanford University
### he/him/his Paper 10Author: Silvia Stacchiotti, MD (she/her/hers) – Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### she/her/hers @@@ Claudia Giani, MD – Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy ### 2102494###Presenter###Medical Oncology resident###Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy###Presenter: Claudia Giani, MD – Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
### @@@ Silva Ljevar, MSc (she/her/hers) – Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2102379###Co-Author###Reserach Fellow###Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Silva Ljevar, MSc (she/her/hers) – Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### she/her/hers @@@ Alexander J. Lazar, MD, PhD (he/him/his) – The University of Texas MD Anderson Cancer Center ### 2102495###Co-Author###Professor of Pathology & Genomic Medicine###The University of Texas MD Anderson Cancer Center###Co-Author: Alexander J. Lazar, MD, PhD (he/him/his) – The University of Texas MD Anderson Cancer Center
### he/him/his @@@ Costanza Figura (she/her/hers) – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2102496###Co-Author###Medical student###Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Costanza Figura (she/her/hers) – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### she/her/hers @@@ Andrea Napolitano, MD (he/him/his) – The Royal Marsden NHS, London, UK ### 2102497###Co-Author###Consultant Medical Oncologist###The Royal Marsden NHS, London, UK###Co-Author: Andrea Napolitano, MD (he/him/his) – The Royal Marsden NHS, London, UK
### he/him/his @@@ Elizabeth Connolly, MD (she/her/hers) – Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia. Faculty of medicine and health, University of Sydney, Sydney, Australia. ### 2102498###Co-Author###Research Fellow###Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia. Faculty of medicine and health, University of Sydney, Sydney, Australia.###Co-Author: Elizabeth Connolly, MD (she/her/hers) – Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia. Faculty of medicine and health, University of Sydney, Sydney, Australia.
### she/her/hers @@@ Emanuela Palmerini, MD, PhD (she/her/hers) – IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy ### 2102499###Co-Author###Consultant Medical Oncologist###IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy###Co-Author: Emanuela Palmerini, MD, PhD (she/her/hers) – IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
### she/her/hers @@@ Roberto Scanferla, MD – Orthopedics Oncology and Reconstructive Surgery Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy ### 2102500###Co-Author######Orthopedics Oncology and Reconstructive Surgery Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy###Co-Author: Roberto Scanferla, MD – Orthopedics Oncology and Reconstructive Surgery Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
### @@@ Jyoti Bajpai, MD, DM (she/her/hers) – Tata Memorial Centre,Homibhabha National University,Mumbai,India ### 2102217###Co-Author###Professor###Tata Memorial Centre,Homibhabha National University,Mumbai,India###Co-Author: Jyoti Bajpai, MD, DM (she/her/hers) – Tata Memorial Centre,Homibhabha National University,Mumbai,India
### she/her/hers @@@ Daniel Wong, n/a – Sir Charles Gairdner Hospital (SCGH), Australia ### 2102501###Co-Author######Sir Charles Gairdner Hospital (SCGH), Australia###Co-Author: Daniel Wong, n/a – Sir Charles Gairdner Hospital (SCGH), Australia
### @@@ Koichi Ogura, MD, PhD (he/him/his) – National Cancer Center Hospital ### 2102502###Co-Author###Head###National Cancer Center Hospital###Co-Author: Koichi Ogura, MD, PhD (he/him/his) – National Cancer Center Hospital
### he/him/his @@@ Chia-Chen Li, MD – National Taiwan University Cancer Center ### 2102503###Co-Author###Attending physician###National Taiwan University Cancer Center###Co-Author: Chia-Chen Li, MD – National Taiwan University Cancer Center
### @@@ Steven Bialick, DO – Sylvester Comprehensive Cancer Center, University of Miami ### 2102086###Co-Author###Medical Oncologist###Sylvester Comprehensive Cancer Center, University of Miami###Co-Author: Steven Bialick, DO – Sylvester Comprehensive Cancer Center, University of Miami
### @@@ Alexander Lee, Consultant – The Christie NHS Foundation Trust ### 2102504###Co-Author###Consultant Medical Oncologist###The Christie NHS Foundation Trust###Co-Author: Alexander Lee, Consultant – The Christie NHS Foundation Trust
### @@@ Yeh Chen Lee, MBBS BMedSci MPhil FRACP (she/her/hers) – Prince of Wales Hospital ### 2102505###Co-Author###Dr###Prince of Wales Hospital###Co-Author: Yeh Chen Lee, MBBS BMedSci MPhil FRACP (she/her/hers) – Prince of Wales Hospital
### she/her/hers @@@ Susie Bae, MBBS, MSc – Peter MacCallum Cancer Centre, Melbourne, VIC, Australia ### 2102506###Co-Author###Medical Oncologist###Peter MacCallum Cancer Centre, Melbourne, VIC, Australia###Co-Author: Susie Bae, MBBS, MSc – Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
### @@@ Sosipatros A. Boikos, MD – Georgetown Lombardi Comprehensive Cancer Center ### 2102507###Co-Author######Georgetown Lombardi Comprehensive Cancer Center###Co-Author: Sosipatros A. Boikos, MD – Georgetown Lombardi Comprehensive Cancer Center
### @@@ Hanna Koseła-Paterczyk, MD PhD – Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology ### 2102508###Co-Author######Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology###Co-Author: Hanna Koseła-Paterczyk, MD PhD – Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology
### @@@ Antonella Brunello, MD – Department of Oncology, IRCCS Istituto Oncologico Veneto, Padua, Italy ### 2102509###Co-Author######Department of Oncology, IRCCS Istituto Oncologico Veneto, Padua, Italy###Co-Author: Antonella Brunello, MD – Department of Oncology, IRCCS Istituto Oncologico Veneto, Padua, Italy
### @@@ Giacomo Giulio Baldi, MD – Medical Oncology Department, "Santo Stefano" Hospital, Prato, Italy ### 2102510###Co-Author###Medical Consultant###Medical Oncology Department, "Santo Stefano" Hospital, Prato, Italy###Co-Author: Giacomo Giulio Baldi, MD – Medical Oncology Department, "Santo Stefano" Hospital, Prato, Italy
### @@@ Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong ### 2101862###Co-Author###Clinical Associate Professor###The Chinese University of Hong Kong###Co-Author: Herbert Ho Fung Loong, MBBS(HK), PDipMDPath(HK), MRCP(UK), FRCP Edin, FHKCP, FHKAM(Medicine) (he/him/his) – The Chinese University of Hong Kong
### he/him/his @@@ Fernando Campos, MD (he/him/his) – Medical Oncology Department, A.C.Camargo Cancer Center, São Paulo, SP, Brazil ### 2102511###Co-Author###Medical Oncologist###Medical Oncology Department, A.C.Camargo Cancer Center, São Paulo, SP, Brazil###Co-Author: Fernando Campos, MD (he/him/his) – Medical Oncology Department, A.C.Camargo Cancer Center, São Paulo, SP, Brazil
### he/him/his @@@ Robert Maki, MD, PhD, FACP, FASCO (he/him/his) – Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center (MSKCC) ### 2102512###Co-Author###Professor of Medicine, Member###Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center (MSKCC)###Co-Author: Robert Maki, MD, PhD, FACP, FASCO (he/him/his) – Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center (MSKCC)
### he/him/his @@@ Carlo M. Cicala, MD – Vall d'Hebron Institute of Oncology ### 2102513###Co-Author###Medical Oncologist / PhD Fellow###Vall d'Hebron Institute of Oncology###Co-Author: Carlo M. Cicala, MD – Vall d'Hebron Institute of Oncology
### @@@ Vladimir Andelkovic, MD – Princess Alexandra Hospital (PAH), Australia ### 2102514###Co-Author###Medical Oncologist###Princess Alexandra Hospital (PAH), Australia###Co-Author: Vladimir Andelkovic, MD – Princess Alexandra Hospital (PAH), Australia
### @@@ Marta Sbaraglia, MD – Department of Pathology, Azienda Ospedale-Università Padova, Padova, Italy ### 2102515###Co-Author######Department of Pathology, Azienda Ospedale-Università Padova, Padova, Italy###Co-Author: Marta Sbaraglia, MD – Department of Pathology, Azienda Ospedale-Università Padova, Padova, Italy
### @@@ Inga-Marie Schaefer, MD (she/her/hers) – Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA ### 2102516###Co-Author###Assistant Professor###Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA###Co-Author: Inga-Marie Schaefer, MD (she/her/hers) – Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
### she/her/hers @@@ Rosalba Miceli, MD, PhD (she/her/hers) – Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2101978###Co-Author###Director of Unit of Biostatistics for Clinical Research###Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Rosalba Miceli, MD, PhD (she/her/hers) – Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### she/her/hers @@@ Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2101980###Co-Author###Chief Sarcoma Service and Chair of the Department of Surgery###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### he/him/his Paper 59Author: Bernadette Brennan, BSC MBChB MD – Royal Manchester Children's Hospital
### @@@ Laura Kirton, Bsc – Cancer Research UK Clinical Trials Unit (CRCTU) ### 2102286###Co-Author######Cancer Research UK Clinical Trials Unit (CRCTU)###Co-Author: Laura Kirton, Bsc – Cancer Research UK Clinical Trials Unit (CRCTU)
### @@@ Françoise Françoise, PhD – UMR_S 1307 Center for Research in Cancer and Integrated Immunology ### 2102287###Co-Author######UMR_S 1307 Center for Research in Cancer and Integrated Immunology###Co-Author: Françoise Françoise, PhD – UMR_S 1307 Center for Research in Cancer and Integrated Immunology
### @@@ Perrine Marec-Berard, MD (she/her/hers) – Centre Léon Bérard ### 2102288###Co-Author###Pediatric Oncologist###Centre Léon Bérard###Co-Author: Perrine Marec-Berard, MD (she/her/hers) – Centre Léon Bérard
### she/her/hers @@@ Javier Martin-Broto, MD, PhD (he/him/his) – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology ### 2101868###Co-Author###Medical oncology###Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology###Co-Author: Javier Martin-Broto, MD, PhD (he/him/his) – Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain; Medical Oncology
### he/him/his @@@ Hans Gelderblom, MD, PhD (he/him/his) – Leiden University Medical Center ### 2101884###Co-Author###Medical Oncologist###Leiden University Medical Center###Co-Author: Hans Gelderblom, MD, PhD (he/him/his) – Leiden University Medical Center
### he/him/his @@@ Sandra J. Strauss, MD PhD FRCP (she/her/hers) – UCL Cancer Institute ### 2102184###Co-Author###Professor of Medical and TYA Oncology###UCL Cancer Institute###Co-Author: Sandra J. Strauss, MD PhD FRCP (she/her/hers) – UCL Cancer Institute
### she/her/hers @@@ Nathalie Gaspar, PhD MD (she/her/hers) – Gustave Roussy cancer campus ### 2102289###Co-Author###Dr at Gustave Roussy ###Gustave Roussy cancer campus###Co-Author: Nathalie Gaspar, PhD MD (she/her/hers) – Gustave Roussy cancer campus
### she/her/hers @@@ Jennifer Anderton, Bsc PhD (she/her/hers) – Cancer Research UK Clinical Trials Unit (CRCTU) ### 2102290###Co-Author###Senior Trial Coordinator###Cancer Research UK Clinical Trials Unit (CRCTU)###Co-Author: Jennifer Anderton, Bsc PhD (she/her/hers) – Cancer Research UK Clinical Trials Unit (CRCTU)
### she/her/hers @@@ Ana Sastre, MD – La Paz Hospital ### 2102291###Co-Author######La Paz Hospital###Co-Author: Ana Sastre, MD – La Paz Hospital
### @@@ Valerie Laurence, MD PhD – Institute Curie ### 2102292###Co-Author######Institute Curie###Co-Author: Valerie Laurence, MD PhD – Institute Curie
### @@@ Cormac Owens, MB FRCPI – 11. Our Lady’s Children’s Hospital, Dublin, Ireland ### 2102293###Co-Author###Paediatric Oncologist###11. Our Lady’s Children’s Hospital, Dublin, Ireland###Co-Author: Cormac Owens, MB FRCPI – 11. Our Lady’s Children’s Hospital, Dublin, Ireland
### @@@ Piers Gaunt, MSc (he/him/his) – Cancer Research UK Clinical Trials Unit (CRCTU) ### 2102294###Co-Author###Principal Biostatistician###Cancer Research UK Clinical Trials Unit (CRCTU)###Co-Author: Piers Gaunt, MSc (he/him/his) – Cancer Research UK Clinical Trials Unit (CRCTU)
### he/him/his @@@ Keith Wheatley, BSc PhD – Cancer Research UK Clinical Trials Unit (CRCTU) ### 2102295###Co-Author######Cancer Research UK Clinical Trials Unit (CRCTU)###Co-Author: Keith Wheatley, BSc PhD – Cancer Research UK Clinical Trials Unit (CRCTU)
### Paper 29Co-Author: Matthew F. Gong, MD – University of Pittsburgh
### @@@ Clark Roth ### 2164311###Co-Author#########Co-Author: Clark Roth
### @@@ William T. Li, MD – University of Pittsburgh Medical Center ### 1771844### Co-Author###Resident Physician###University of Pittsburgh Medical Center###Co-Author: William T. Li, MD – University of Pittsburgh Medical Center
### @@@ Sumail Bhogal, MD – University of Pittsburgh Medical Center ### 1771845### Co-Author###Resident Physician###University of Pittsburgh Medical Center###Co-Author: Sumail Bhogal, MD – University of Pittsburgh Medical Center
### @@@ Brittany J. Royes, N/A, MS – University of Pittsburgh ### 1771847### Co-Author######University of Pittsburgh###Co-Author: Brittany J. Royes, N/A, MS – University of Pittsburgh
### @@@ Tanya Heim, MS – University of Pittsburgh ### 1771848### Co-Author###Lab Manager ###University of Pittsburgh###Co-Author: Tanya Heim, MS – University of Pittsburgh
### @@@ Marcus Malek, MD – Children's Hospital of Pittsburgh ### 2103695### Co-Author###Director, Pediatric Surgical Oncology###Children's Hospital of Pittsburgh###Co-Author: Marcus Malek, MD – Children's Hospital of Pittsburgh
### @@@ Rajeev Dhupar, MD – University of Pittsburgh Medical Center ### 2103696### Co-Author######University of Pittsburgh Medical Center###Co-Author: Rajeev Dhupar, MD – University of Pittsburgh Medical Center
### @@@ Stella J. Lee, MD – University of Pittsburgh Medical Center ### 1771850### Co-Author###Assistant Professor###University of Pittsburgh Medical Center###Co-Author: Stella J. Lee, MD – University of Pittsburgh Medical Center
### @@@ Richard L. McGough, III, MD – University of Pittsburgh Medical Center ### 1771851### Co-Author###Professor and Chief###University of Pittsburgh Medical Center###Co-Author: Richard L. McGough, III, MD – University of Pittsburgh Medical Center
### @@@ Kurt R. Weiss, MD (he/him/his) – University of Pittsburgh ### 1136427###Presenter###Associate Professor###University of Pittsburgh###Presenter: Kurt R. Weiss, MD (he/him/his) – University of Pittsburgh
### he/him/hisAuthor: Laura Bergamaschi, MSc (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
### she/her/hers @@@ Marta Zorza, n/a – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2102571###Co-Author######Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Marta Zorza, n/a – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Francesca Rini, n/a – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2102572###Co-Author######Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Francesca Rini, n/a – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Federica Perrone – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2102573###Co-Author###staff member, senior researcher###Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Federica Perrone – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ licia Rivoltini, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2102574###Co-Author######Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: licia Rivoltini, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2101980###Co-Author###Chief Sarcoma Service and Chair of the Department of Surgery###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### he/him/his @@@ Sandro Pasquali, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2102575###Co-Author######Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Sandro Pasquali, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Viviana Vallacchi, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 2102576###Co-Author###Senior Scientist ###Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Viviana Vallacchi, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Chiara Colombo, MD – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 2102378###Presenter###Surgical Oncologist###Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Presenter: Chiara Colombo, MD – Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### Paper 42Video Presenter: Shintaro Iwata, MD (he/him/his) – National Cancer Center Hospital
### he/him/his Video 02Basic Science Sarcoma Research Award Winner: Isidro Cortes-Ciriano, PhD – EMBL-EBI
###